Glimepiride Use Reduces the Risk of Cardiovascular Mortality in Patients With Type 2 Diabetes and Chronic Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Glimepiride Use is Associated with Reduced Cardiovascular Mortality in Patients with Type 2 Diabetes and Chronic Heart Failure: A Prospective Cohort Study
Eur J Prev Cardiol 2022 Dec 27;[EPub Ahead of Print], W He, G Yuan, Y Han, Y Yan, G Li, C Zhao, J Shen, X Jiang, C Chen, L Ni, DW WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.